TOVX icon

Theriva Biologics
TOVX

Overview Fund Activity

24 hedge funds and large institutions have $830K invested in Theriva Biologics in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
5
Reduced
5
Closed
4
Calls
$2.65M
Puts
–
Net Calls
+$2.65M
Net Calls Change
+$278K

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$295K
2
WS
2
Wedbush Securities
California
$67K
3
Deutsche Bank
3
Deutsche Bank
Germany
$2K
4
BlackRock
4
BlackRock
New York
$20K

Top Sellers

1
SM
1
Sabby Management
Florida
$348K
2
Goldman Sachs
2
Goldman Sachs
New York
$0
3
6CM
3
683 Capital Management
New York
$0
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$0
5
Victory Capital Management
5
Victory Capital Management
Texas
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AG
26
Advisor Group
Arizona
$0 421 – –
VFA
27
Valeo Financial Advisors
Indiana
$0 858 – –
TRCT
28
Tower Research Capital (TRC)
New York
$0 100 – –
SAM
29
Scopus Asset Management
New York
– – – –
Bank of America
30
Bank of America
North Carolina
$0 75 +17 +29%
Morgan Stanley
31
Morgan Stanley
New York
$0 287 +71 +33%
1
2